Cyclo Therapeutics, Inc.·4

Sep 28, 9:47 AM ET

Kjems Lise Lund 4

4 · Cyclo Therapeutics, Inc. · Filed Sep 28, 2021

Insider Transaction Report

Form 4
Period: 2021-09-27
Kjems Lise Lund
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-09-27+17,05317,053 total
  • Award

    Stock Option (Right to buy)

    2021-09-27+23,80023,800 total
    Exercise: $7.33Exp: 2031-09-27Common Stock (23,800 underlying)
Footnotes (1)
  • [F1]The option vests immediately with respect to one-quarter of the shares of common stock subject to the option, and vests with respect to the remaining shares over a four-year period in 48 equal monthly installments on the first day of each month following the date of grant.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4